The cancer-promoting effect of hyperinsulinemia is based on the knowledge that insulin has both metabolic and mitogenic actions via its own receptor in addition to the IGF-1R, which is activated by insulin with a much lower affinity. The gene discussed is IGF1R; the disease is cancer.